Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00219440 · ClinicalTrials.gov registry record · Phase 4
A Portion-controlled Diet Will Prevent Weight Gain in Diabetics Treated With ACTOS
A Phase 4 study, sponsored by Pennington Biomedical Research Center.
- Completed
- Registry status
- Phase 4
- Development phase
- 60
- Enrollment target
NCT00219440: Completed Phase 4 study, sponsored by Pennington Biomedical Research Center.
NCT00219440 is a Phase 4 study that has completed, run by Pennington Biomedical Research Center. The registered enrollment target is 60 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (88% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00219440, a Phase 4 study, has completed, sponsored by Pennington Biomedical Research Center.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 60 participants
- Enrollment target
Study Summary
We hypothesized that a portion controlled diet would prevent the weight gain associated with the use of a peroxisome profliferator-activated receptor-gamma (PPAR-g). This is a 4 months randomized clinical trial in type 2 diabetics who are treated with pioglitazone and a standard diet, pioglitazone and a portion-controlled diet and metformin with a standard diet.
Interventions
- OTHER Actos plus standard diet
- OTHER Actos plus structured diet
- OTHER Metformin plus standard diet
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2003-02 |
| Est. Completion | 2006-12 |
| Phase | Phase 4 |
What the finished NCT00219440 record still lists
NCT00219440 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (88% lower).
The record links to 0 conditions, and to 3 interventions - of which Actos plus standard diet is the first listed.
NCT00219440 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00219440 about?
NCT00219440 is a clinical study titled "A Portion-controlled Diet Will Prevent Weight Gain in Diabetics Treated With ACTOS". We hypothesized that a portion controlled diet would prevent the weight gain associated with the use of a peroxisome profliferator-activated receptor-gamma (PPAR-g). This is a 4 months randomized clinical trial in type 2 diabetics who are treated with pioglitazone and a standard diet, pioglitazone a...
What is the current status of trial NCT00219440?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 60 participants. The study started on 2003-02. Estimated completion is 2006-12.
What interventions are being tested in trial NCT00219440?
The interventions under investigation include: Actos plus standard diet (OTHER), Actos plus structured diet (OTHER), Metformin plus standard diet (OTHER).
Who is sponsoring clinical trial NCT00219440?
This trial is sponsored by Pennington Biomedical Research Center, which has 258 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00219440's enrollment target sits among peer trials
60 1125th of 2000 higher than 799 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia